{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:05:34Z","timestamp":1790345134211,"version":"4.1.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770741"],"award-info":[{"award-number":["81770741"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570603"],"award-info":[{"award-number":["81570603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lfs.2020.118379","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:53:57Z","timestamp":1599080037000},"page":"118379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"special_numbering":"C","title":["Advances in the pathogenesis and prevention of contrast-induced nephropathy"],"prefix":"10.1016","volume":"259","author":[{"given":"Fangfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0005","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1148\/rg.2015150033","article-title":"Safe use of contrast media: what the radiologist needs to know","volume":"35","author":"Beckett","year":"2015","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.lfs.2020.118379_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.mric.2017.06.012","article-title":"Contrast-induced acute kidney injury: pathophysiology, manifestations, prevention, and management","volume":"25","author":"Scharnweber","year":"2017","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/kisup.2011.34","article-title":"Section 4: contrast-induced Aki","volume":"2","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.lfs.2020.118379_bb0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ki.5000366","article-title":"Contrast-induced nephrotoxicity: clinical landscape","volume":"100","author":"Katzberg","year":"2006","journal-title":"Kidney Int. Suppl."},{"issue":"5","key":"10.1016\/j.lfs.2020.118379_bb0025","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/j.lfs.2020.118379_bb0030","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jcin.2014.06.023","volume":"7","author":"Toso","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2013.06.016","article-title":"Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry","volume":"7","author":"Tsai","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.lfs.2020.118379_bb0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijcard.2016.09.033","article-title":"Hyperuricemia and contrast-induced acute kidney injury: a systematic review and meta-analysis","volume":"224","author":"Zuo","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.lfs.2020.118379_bb0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2011.05.023","article-title":"Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions","volume":"58","author":"Gurm","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118379_bb0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1681\/ASN.2016010021","article-title":"Estimating the risk of radiocontrast-associated nephropathy","volume":"28","author":"Wilhelm-Leen","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.12121460","article-title":"Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis","volume":"267","author":"McDonald","year":"2013","journal-title":"Radiology"},{"issue":"13","key":"10.1016\/j.lfs.2020.118379_bb0060","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-induced acute kidney injury","volume":"68","author":"McCullough","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.lfs.2020.118379_bb0065","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury","volume":"380","author":"Mehran","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0070","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1172\/JCI96640","article-title":"Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury","volume":"128","author":"Lau","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"20","key":"10.1016\/j.lfs.2020.118379_bb0075","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehn197","article-title":"Contrast agents and renal cell apoptosis","volume":"29","author":"Romano","year":"2008","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1523-1755.2003.00059.x","article-title":"Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity","volume":"64","author":"Zager","year":"2003","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004424-199101000-00007","article-title":"Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats","volume":"26","author":"Battenfeld","year":"1991","journal-title":"Investig. Radiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2215\/CJN.02600607","article-title":"Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy","volume":"3","author":"Heyman","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0095","doi-asserted-by":"crossref","first-page":"F319","DOI":"10.1152\/ajprenal.00130.2017","article-title":"Prevention of contrast-induced nephropathy by limb ischemic preconditioning: underlying mechanisms and clinical effects","volume":"314","author":"Dugbartey","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0100","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1159\/000146075","article-title":"Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease","volume":"28","author":"Heyman","year":"2008","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118379_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2011.06.115","article-title":"Pathophysiology of contrast-induced nephropathy","volume":"158","author":"Wong","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118379_bb0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ki.1991.255","article-title":"Early renal medullary hypoxic injury from radiocontrast and indomethacin","volume":"40","author":"Heyman","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2020.118379_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2017.06.009","article-title":"Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies","volume":"180","author":"Mamoulakis","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.118379_bb0120","doi-asserted-by":"crossref","first-page":"931413","DOI":"10.1155\/2014\/931413","article-title":"Is contrast medium osmolality a causal factor for contrast-induced nephropathy?","volume":"2014","author":"Bucher","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00004424-197801000-00015","article-title":"A comparison of the hemodynamic responses to metrizamide and meglumine\/sodium diatrizoate in canine renal angiography","volume":"13","author":"Morris","year":"1978","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.lfs.2020.118379_bb0130","doi-asserted-by":"crossref","first-page":"358136","DOI":"10.1155\/2014\/358136","article-title":"Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies","volume":"2014","author":"Seeliger","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/TP.0000000000001999","article-title":"Ischemia-reperfusion injury in aged livers-the energy metabolism, inflammatory response, and autophagy","volume":"102","author":"Kan","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.lfs.2020.118379_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"issue":"4","key":"10.1016\/j.lfs.2020.118379_bb0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.HYP.0000240347.51386.ea","article-title":"Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin ii-dependent hypertension","volume":"48","author":"Zhao","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00204-010-0626-5","article-title":"Nephrotoxicity of contrast media and protective effects of acetylcysteine","volume":"85","author":"Briguori","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118379_bb0155","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0002-9440(10)62352-8","article-title":"A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic amp response element binding protein","volume":"166","author":"Yano","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118379_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000259899","article-title":"Jnk\/atf2 pathway is involved in iodinated contrast media-induced apoptosis","volume":"31","author":"Lee","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"1041","key":"10.1016\/j.lfs.2020.118379_bb0165","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130738","article-title":"The role of inflammation in contrast-induced nephropathy","volume":"87","author":"Kwasa","year":"2014","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.lfs.2020.118379_bb0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ebiom.2017.02.009","article-title":"Antithrombin iii protects against contrast-induced nephropathy","volume":"17","author":"Lu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lfs.2020.118379_bb0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ebiom.2016.05.017","article-title":"Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase","volume":"9","author":"Wang","year":"2016","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.lfs.2020.118379_bb0180","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical nf-\u03bab pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2020.118379_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of nf-\u03bab: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.lfs.2020.118379_bb0190","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/ndt\/gfr807","article-title":"Sodium butyrate decreases the activation of nf-\u03bab reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathy","volume":"27","author":"Machado","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2020.118379_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15402","article-title":"Antigen-specific cd8(+) t cell feedback activates nlrp3 inflammasome in antigen-presenting cells through perforin","volume":"8","author":"Yao","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.lfs.2020.118379_bb0200","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/01.CCM.0000233878.36340.10","article-title":"Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury","volume":"34","author":"Furuichi","year":"2006","journal-title":"Crit. Care Med."},{"issue":"7006","key":"10.1016\/j.lfs.2020.118379_bb0205","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal micrornas","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2020.118379_bb0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.lfs.2020.118379_bb0215","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3109\/0886022X.2015.1077322","article-title":"Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human","volume":"37","author":"Guti\u00e9rrez-Escolano","year":"2015","journal-title":"Ren. Fail."},{"issue":"8","key":"10.1016\/j.lfs.2020.118379_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004138","article-title":"Circulating microrna-188, -30a, and -30e as early biomarkers for contrast-induced acute kidney injury","volume":"5","author":"Sun","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.lfs.2020.118379_bb0225","doi-asserted-by":"crossref","first-page":"178","DOI":"10.21037\/atm.2019.04.44","article-title":"MicroRNA expression profile by next-generation sequencing in a novel rat model of contrast-induced acute kidney injury","volume":"7","author":"Liu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"16","key":"10.1016\/j.lfs.2020.118379_bb0230","doi-asserted-by":"crossref","first-page":"378","DOI":"10.21037\/atm.2019.07.20","article-title":"Microrna-188 aggravates contrast-induced apoptosis by targeting srsf7 in novel isotonic contrast-induced acute kidney injury rat models and renal tubular epithelial cells","volume":"7","author":"Liu","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.lfs.2020.118379_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106457","article-title":"Microrna-30c attenuates contrast-induced acute kidney injury by suppressing nlrp3 inflammasome","volume":"87","author":"Xu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0240","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00330-017-5247-4","article-title":"Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR contrast medium safety committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0245","first-page":"1","article-title":"Contrast-induced nephropathy: pathophysiology, risk factors, and prevention","volume":"29","author":"Hossain","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.lfs.2020.118379_bb0250","doi-asserted-by":"crossref","first-page":"h4395","DOI":"10.1136\/bmj.h4395","article-title":"Risk prediction models for contrast induced nephropathy: systematic review","volume":"351","author":"Silver","year":"2015","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0255","first-page":"369","article-title":"Predicting contrast-induced renal complications in the catheterization laboratory","volume":"3","author":"Kooiman","year":"2014","journal-title":"Interv Cardiol Clin"},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0260","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol."},{"issue":"12","key":"10.1016\/j.lfs.2020.118379_bb0265","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2004.03.008","article-title":"Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification","volume":"93","author":"Bartholomew","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0270","first-page":"E8","article-title":"A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention","volume":"83","author":"Chen","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0275","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10157-014-0942-9","article-title":"Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients","volume":"18","author":"Gao","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.lfs.2020.118379_bb0280","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijcard.2016.12.095","article-title":"A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention","volume":"230","author":"Lin","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0285","doi-asserted-by":"crossref","first-page":"350","DOI":"10.14740\/cr939","article-title":"Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction","volume":"10","author":"Koowattanatianchai","year":"2019","journal-title":"Cardiol Res"},{"key":"10.1016\/j.lfs.2020.118379_bb0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2014.11.133","article-title":"A simple pre-procedural risk score for contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention","volume":"180","author":"Liu","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118379_bb0295","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004498","article-title":"Preprocedural prediction model for contrast-induced nephropathy patients","volume":"6","author":"Yin","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.lfs.2020.118379_bb0300","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.21037\/jtd.2019.04.69","article-title":"Simple pre-procedure risk stratification tool for contrast-induced nephropathy","volume":"11","author":"Ni","year":"2019","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.lfs.2020.118379_bb0305","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1536\/ihj.16-129","article-title":"Pre-procedural risk score of contrast-induced nephropathy in elderly patients undergoing elective coronary angiography","volume":"58","author":"Lian","year":"2017","journal-title":"Int. Heart J."},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0310","first-page":"714","article-title":"A new preprocedure risk score for predicting contrast-induced acute kidney injury","volume":"33","author":"Duan","year":"2017","journal-title":"Can J Cardiol"},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0315","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2459\/JCM.0000000000000215","article-title":"Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization","volume":"17","author":"Capodanno","year":"2016","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"10","key":"10.1016\/j.lfs.2020.118379_bb0320","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11255-016-1348-2","article-title":"Does n-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?","volume":"48","author":"Liu","year":"2016","journal-title":"Int. Urol. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118379_bb0325","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/joic.12315","article-title":"Comparison of two risk models in predicting the incidence of contrast-induced nephropathy after percutaneous coronary intervention","volume":"29","author":"Araujo","year":"2016","journal-title":"J. Interv. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0330","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12928-017-0472-y","article-title":"Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score","volume":"33","author":"Araujo","year":"2018","journal-title":"Cardiovasc. Interv. Ther."},{"key":"10.1016\/j.lfs.2020.118379_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8736163","article-title":"Risk prediction for contrast-induced nephropathy in cancer patients undergoing computed tomography under preventive measures","volume":"2019","author":"Jeon","year":"2019","journal-title":"J Oncol"},{"issue":"22","key":"10.1016\/j.lfs.2020.118379_bb0340","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.jacc.2013.03.026","article-title":"A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention","volume":"61","author":"Gurm","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118379_bb0345","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/clc.23143","article-title":"A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography","volume":"42","author":"Ibrahim","year":"2019","journal-title":"Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00134-003-2078-3","article-title":"Defining acute renal failure: physiological principles","volume":"30","author":"Bellomo","year":"2004","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.lfs.2020.118379_bb0355","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.12659\/MSM.897241","article-title":"Significance of cystatin c for early diagnosis of contrast-induced nephropathy in patients undergoing coronary angiography","volume":"22","author":"Wang","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.lfs.2020.118379_bb0360","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/JIM.0000000000000243","article-title":"Is kidney injury molecule 1 a valuable tool for the early diagnosis of contrast-induced nephropathy?","volume":"63","author":"Akdeniz","year":"2015","journal-title":"J. Investig. Med."},{"issue":"8","key":"10.1016\/j.lfs.2020.118379_bb0365","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/clc.22551","article-title":"Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after elective invasive cardiac procedures","volume":"39","author":"Kafkas","year":"2016","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.lfs.2020.118379_bb0370","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.toxlet.2019.10.011","article-title":"Optimal measuring timing of cystatin c for early detection of contrast-induced acute kidney injury: a systematic review and meta-analysis","volume":"318","author":"Chen","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2020.118379_bb0375","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2019.09.069","article-title":"A single cystatin c determination before coronary angiography can predict short and long-term adverse events","volume":"300","author":"Budano","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118379_bb0380","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3892\/etm.2014.1898","article-title":"Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention","volume":"8","author":"He","year":"2014","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0385","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/1995-705X.125926","article-title":"Contrast-induced nephropathy","volume":"14","author":"Mohammed","year":"2013","journal-title":"Heart Views: The Official Journal of the Gulf Heart Association"},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0390","doi-asserted-by":"crossref","first-page":"e84916","DOI":"10.1172\/jci.insight.84916","article-title":"Tubular dickkopf-3 promotes the development of renal atrophy and fibrosis","volume":"1","author":"Federico","year":"2016","journal-title":"JCI Insight"},{"issue":"10197","key":"10.1016\/j.lfs.2020.118379_bb0395","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0140-6736(19)30769-X","article-title":"Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study","volume":"394","author":"Schunk","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0400","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","article-title":"Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media","volume":"188","author":"Barrett","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118379_bb0405","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2018.08.097","article-title":"Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: comparison of five contrast media","volume":"273","author":"Azzalini","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0410","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","article-title":"Pathophysiology of contrast medium-induced nephropathy","volume":"68","author":"Persson","year":"2005","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0415","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0420","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jvs.2006.11.017","article-title":"Carbon dioxide digital subtraction angiography-assisted endovascular aortic aneurysm repair in the azotemic patient","volume":"45","author":"Chao","year":"2007","journal-title":"J. Vasc. Surg."},{"issue":"9","key":"10.1016\/j.lfs.2020.118379_bb0425","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0003319715614701","article-title":"Carbondioxide-aided angiography decreases contrast volume and preserves kidney function in peripheral vascular interventions","volume":"67","author":"Stegemann","year":"2016","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.lfs.2020.118379_bb0430","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2008.496","article-title":"Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (mr) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?","volume":"75","author":"Neuwelt","year":"2009","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.lfs.2020.118379_bb0435","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrneph.2010.116","article-title":"Contrast-induced acute kidney injury and diabetic nephropathy","volume":"6","author":"Calvin","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0440","article-title":"Zero-contrast percutaneous coronary intervention guided by dextran-based optical coherence tomography","volume":"34","author":"Azzalini","year":"2018","journal-title":"Can J Cardiol."},{"issue":"15","key":"10.1016\/j.lfs.2020.118379_bb0445","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/01.CIR.103.15.1999","article-title":"Index matching to improve optical coherence tomography imaging through blood","volume":"103","author":"Brezinski","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0450","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2010.01.065","article-title":"Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention","volume":"56","author":"Duffy","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0455","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.carrev.2007.05.003","article-title":"Removal of contrast medium from the coronary sinus during coronary angiography: feasibility of a simple and available technique for the prevention of nephropathy","volume":"9","author":"Danenberg","year":"2008","journal-title":"Cardiovasc Revasc Med"},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0460","doi-asserted-by":"crossref","first-page":"e004348","DOI":"10.1161\/CIRCINTERVENTIONS.116.004348","article-title":"Efficacy and safety of coronary sinus aspiration during coronary angiography to attenuate the risk of contrast-induced acute kidney injury in predisposed patients","volume":"10","author":"Diab","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0465","first-page":"1228","article-title":"The use of the avert system to limit contrast volume administration during peripheral angiography and intervention","volume":"86","author":"Prasad","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.lfs.2020.118379_bb0470","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2017.12.107","article-title":"Impact of a novel contrast reduction system on contrast savings in coronary angiography - the DyeVert randomised controlled trial","volume":"257","author":"Desch","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"16","key":"10.1016\/j.lfs.2020.118379_bb0475","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jcin.2018.04.007","article-title":"Effect of a contrast modulation system on contrast media use and the rate of acute kidney injury after coronary angiography","volume":"11","author":"Mehran","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.lfs.2020.118379_bb0480","first-page":"741018","article-title":"Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention","volume":"2014","author":"Andreucci","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.lfs.2020.118379_bb0485","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/RLI.0000000000000570","article-title":"Prophylaxis in high-risk patients with eGFR < 30 ml\/min\/1.73 m2: get the balance right","volume":"54","author":"Nijssen","year":"2019","journal-title":"Investig. Radiol."},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0490","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1007\/s00330-020-06719-7","article-title":"Impact on clinical practice of updated guidelines on iodinated contrast material: CINART","volume":"30","author":"Nijssen","year":"2020","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0495","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcin.2015.10.014","article-title":"Improving intravenous fluid therapy for prevention of contrast-induced nephropathy: how to give more without causing heart failure","volume":"9","author":"Solomon","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0500","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcin.2015.09.026","article-title":"Prevention of contrast-induced nephropathy by central venous pressure-guided fluid administration in chronic kidney disease and congestive heart failure patients","volume":"9","author":"Qian","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"25","key":"10.1016\/j.lfs.2020.118379_bb0505","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.jacc.2018.04.022","article-title":"Bioimpedance-guided hydration for the prevention of contrast-induced kidney injury: the hydra study","volume":"71","author":"Maioli","year":"2018","journal-title":"J Am Coll Cardiol."},{"issue":"9931","key":"10.1016\/j.lfs.2020.118379_bb0510","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lfs.2020.118379_bb0515","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcin.2016.11.006","article-title":"Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Putzu","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"issue":"11","key":"10.1016\/j.lfs.2020.118379_bb0520","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.111.030759","article-title":"Renal insufficiency after contrast media administration trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury","volume":"124","author":"Briguori","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.lfs.2020.118379_bb0525","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jcin.2015.07.012","volume":"8","author":"Barbanti","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0530","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcin.2011.08.017","article-title":"Prevention of contrast nephropathy by furosemide with matched hydration: the mythos (induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) trial","volume":"5","author":"Marenzi","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0535","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2459\/JCM.0000000000000348","article-title":"AKIGUARD (acute kidney injury guarding device) trial: in-hospital and one-year outcomes","volume":"17","author":"Usmiani","year":"2016","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.lfs.2020.118379_bb0540","article-title":"Renal insufficiency following contrast media administration trial III: urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design","author":"Briguori","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0545","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"Leoncini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.lfs.2020.118379_bb0550","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1161\/CIRCULATIONAHA.112.103317","article-title":"Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury","volume":"126","author":"Quintavalle","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2011.03.001","volume":"108","author":"Patti","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.lfs.2020.118379_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2009.01.035","article-title":"High-dose n-acetylcysteine for the prevention of contrast-induced nephropathy","volume":"122","author":"Trivedi","year":"2009","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0565","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.lfs.2020.118379_bb0570","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.111.038943","article-title":"Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (act)","volume":"124","year":"2011","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.lfs.2020.118379_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194961","article-title":"Quercetin, a promising clinical candidate for the prevention of contrast-induced nephropathy","volume":"20","author":"Vicente-Vicente","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118379_bb0580","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.freeradbiomed.2019.09.027","article-title":"Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase","volume":"145","author":"Yang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2020.118379_bb0585","doi-asserted-by":"crossref","first-page":"F881","DOI":"10.1152\/ajprenal.00297.2018","article-title":"The protective effect of klotho against contrast-associated acute kidney injury via the antioxidative effect","volume":"317","author":"Oh","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0590","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.ajkd.2012.02.332","article-title":"Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials","volume":"60","author":"Dai","year":"2012","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0595","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.2233010609","article-title":"Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study","volume":"223","author":"Huber","year":"2002","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.lfs.2020.118379_bb0600","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s001340101003","article-title":"Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk","volume":"27","author":"Huber","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.lfs.2020.118379_bb0605","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2016.10.010","article-title":"Asymmetric dimethylarginine predicts the risk of contrast-induced acute kidney injury in patients undergoing cardiac catheterization","volume":"254","author":"Lu","year":"2016","journal-title":"Atherosclerosis"},{"issue":"23","key":"10.1016\/j.lfs.2020.118379_bb0610","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1042\/CS20190455","article-title":"Ddah-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase","volume":"133","author":"Lin","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.lfs.2020.118379_bb0615","doi-asserted-by":"crossref","first-page":"111535","DOI":"10.1016\/j.fct.2020.111535","article-title":"Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy","author":"Iordache","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2020.118379_bb0620","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fphar.2020.00044","article-title":"Protective effects of amlodipine pretreatment on contrast-induced acute kidney injury and overall survival in hypertensive patients","volume":"11","author":"Yin","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.lfs.2020.118379_bb0625","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1161\/CIRCULATIONAHA.109.863159","article-title":"Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention","volume":"120","author":"Spargias","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0630","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/HCO.0b013e3283653f41","article-title":"Therapeutic strategies to prevent contrast-induced acute kidney injury","volume":"28","author":"Quintavalle","year":"2013","journal-title":"Curr. Opin. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118379_bb0635","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.112.096370","article-title":"Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro trial (renal protection trial)","volume":"126","author":"Er","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.lfs.2020.118379_bb0640","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1253\/circj.CJ-13-0171","article-title":"Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease","volume":"77","author":"Igarashi","year":"2013","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.lfs.2020.118379_bb0645","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13054-016-1272-y","article-title":"Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis","volume":"20","author":"Hu","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.lfs.2020.118379_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.12.033","article-title":"The European and Chinese cardiac and renal remote ischemic preconditioning study (EURO-CRIPS CardioGroup I): a randomized controlled trial","volume":"257","author":"Moretti","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118379_bb0655","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/jcmm.12527","article-title":"Renalase contributes to the renal protection of delayed ischaemic preconditioning via the regulation of hypoxia-inducible factor-1alpha","volume":"19","author":"Wang","year":"2015","journal-title":"J. Cell. Mol. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520311322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520311322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:44:16Z","timestamp":1777423456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520311322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":131,"alternative-id":["S0024320520311322"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118379","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the pathogenesis and prevention of contrast-induced nephropathy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118379"}}